Literature DB >> 21852762

Treatment and microbiology of repeated cerebrospinal fluid shunt infections in children.

Teresa J Tuan1, Emily A Thorell, Nicole Mayer Hamblett, John R W Kestle, Margaret Rosenfeld, Tamara D Simon.   

Abstract

BACKGROUND: A small group of children have second and even more cerebrospinal fluid (CSF) shunt infections (SIs). We sought to describe the treatment approaches used for, and the microbiology of, repeated SIs.
METHODS: The study population included 31 children with second shunt infection (SI-2) among those undergoing initial CSF shunt placement and treatment for initial infection at Primary Children's Medical Center. CSF SI was defined as follows: (1) presence of bacteria in Gram stain and/or culture of CSF, wound, and/or pseudocyst; (2) visible hardware; (3) abdominal pseudocyst; or (4) presence of bacteria in a blood culture in children with a ventriculoatrial shunt. Infection rates were generated using per-patient denominators, and the concordance of organisms across infections was summarized.
RESULTS: Of the 31 children with SI-2, most were less than 6 months of age at initial shunt placement (81%), male (77%), and with ventriculoperitoneal shunts (71%). Of total, 18 developed SI-3 and 8 developed SI-4. Infection rates were 60% (95% confidence interval [CI]: 42%-75%, n = 18/30) for SI-3 and 47% (95% CI: 26%-69%, n = 8/17) for SI-4. The median time to SI-3 was 477 days (range, 5-828) and to SI-4 it was 2137 days (range, 9-2137). Gram-positive organisms predominated (93% of SI-2, 94% of SI-3). The majority of SI-2 demonstrated Gram-stain concordance with both the initial (first) SI (58%, 95% CI: 41%-74%) and with the following (third) SI (78%, 95% CI: 55%-91%).
CONCLUSIONS: Children with SI-2 experience high subsequent reinfection rates with a long time to reinfection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852762      PMCID: PMC3160174          DOI: 10.1097/INF.0b013e318218ac0e

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  19 in total

1.  Long-term follow-up data from the Shunt Design Trial.

Authors:  J Kestle; J Drake; R Milner; C Sainte-Rose; G Cinalli; F Boop; J Piatt; S Haines; S Schiff; D Cochrane; P Steinbok; N MacNeil
Journal:  Pediatr Neurosurg       Date:  2000-11       Impact factor: 1.162

2.  A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative.

Authors:  John R W Kestle; Jay Riva-Cambrin; John C Wellons; Abhaya V Kulkarni; William E Whitehead; Marion L Walker; W Jerry Oakes; James M Drake; Thomas G Luerssen; Tamara D Simon; Richard Holubkov
Journal:  J Neurosurg Pediatr       Date:  2011-07       Impact factor: 2.375

3.  The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons.

Authors:  W E Whitehead; J R Kestle
Journal:  Pediatr Neurosurg       Date:  2001-10       Impact factor: 1.162

4.  Repeat cerebrospinal fluid shunt infection in children.

Authors:  A V Kulkarni; D Rabin; M Lamberti-Pasculli; J M Drake
Journal:  Pediatr Neurosurg       Date:  2001-08       Impact factor: 1.162

5.  Reinfection following initial cerebrospinal fluid shunt infection.

Authors:  Tamara D Simon; Matthew Hall; J Michael Dean; John R W Kestle; Jay Riva-Cambrin
Journal:  J Neurosurg Pediatr       Date:  2010-09       Impact factor: 2.375

6.  High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission.

Authors:  M H Samore; M K Magill; S C Alder; E Severina; L Morrison-De Boer; J L Lyon; K Carroll; J Leary; M B Stone; D Bradford; J Reading; A Tomasz; M A Sande
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

7.  Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.

Authors:  Chi-Hui Cheng; Ming-Horng Tsai; Yhu-Chering Huang; Lin-Hui Su; Yong-Kwei Tsau; Chi-Jen Lin; Cheng-Hsun Chiu; Tzou-Yien Lin
Journal:  Pediatrics       Date:  2008-12       Impact factor: 7.124

8.  The influence of surgical operative experience on the duration of first ventriculoperitoneal shunt function and infection.

Authors:  D D Cochrane; J R W Kestle
Journal:  Pediatr Neurosurg       Date:  2003-06       Impact factor: 1.162

9.  Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article.

Authors:  Tamara D Simon; Matthew Hall; Jay Riva-Cambrin; J Elaine Albert; Howard E Jeffries; Bonnie Lafleur; J Michael Dean; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2009-08       Impact factor: 2.375

10.  Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens.

Authors:  Matthew J McGirt; Aimee Zaas; Herbert E Fuchs; Timothy M George; Keith Kaye; Daniel J Sexton
Journal:  Clin Infect Dis       Date:  2003-03-18       Impact factor: 9.079

View more
  15 in total

1.  Prevention options for ventriculoperitoneal shunt infections: a retrospective analysis during a five-year period.

Authors:  Xing Wu; Qin Liu; Xiaofei Jiang; Tao Zhang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Few Patient, Treatment, and Diagnostic or Microbiological Factors, Except Complications and Intermittent Negative Cerebrospinal Fluid (CSF) Cultures During First CSF Shunt Infection, Are Associated With Reinfection.

Authors:  Tamara D Simon; Nicole Mayer-Hamblett; Kathryn B Whitlock; Marcie Langley; John R W Kestle; Jay Riva-Cambrin; Margaret Rosenfeld; Emily A Thorell
Journal:  J Pediatric Infect Dis Soc       Date:  2013-08-26       Impact factor: 3.164

3.  Microbiology and treatment of cerebrospinal fluid shunt infections in children.

Authors:  Daniel J Adams; Michael Rajnik
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

4.  Association of intraventricular hemorrhage secondary to prematurity with cerebrospinal fluid shunt surgery in the first year following initial shunt placement.

Authors:  Tamara D Simon; Kathryn B Whitlock; Jay Riva-Cambrin; John R W Kestle; Margaret Rosenfeld; J Michael Dean; Richard Holubkov; Marcie Langley; Nicole Mayer-Hamblett
Journal:  J Neurosurg Pediatr       Date:  2012-01       Impact factor: 2.375

5.  Use of quantitative 16S rRNA PCR to determine bacterial load does not augment conventional cerebrospinal fluid (CSF) cultures among children undergoing treatment for CSF shunt infection.

Authors:  Tamara D Simon; Brian Van Yserloo; Kevin Nelson; David Gillespie; Randy Jensen; James P McAllister; Jay Riva-Cambrin; Chris Stockmann; Judy A Daly; Anne J Blaschke
Journal:  Diagn Microbiol Infect Dis       Date:  2013-08-13       Impact factor: 2.803

6.  Cerebrospinal Fluid Shunt Infection: Emerging Paradigms in Pathogenesis that Affect Prevention and Treatment.

Authors:  Tamara D Simon; Joshua K Schaffzin; Charles B Stevenson; Kathryn Willebrand; Matthew Parsek; Lucas R Hoffman
Journal:  J Pediatr       Date:  2018-12-06       Impact factor: 4.406

7.  Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2018-02-02       Impact factor: 2.375

8.  Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy Gove; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatr       Date:  2016-09-28       Impact factor: 4.406

Review 9.  Pediatric hospital medicine role in the comanagement of the hospitalized surgical patient.

Authors:  Joshua K Schaffzin; Tamara D Simon
Journal:  Pediatr Clin North Am       Date:  2014-05-20       Impact factor: 3.278

10.  Patient and Treatment Characteristics by Infecting Organism in Cerebrospinal Fluid Shunt Infection.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis N Shannon; Mandeep Tamber; John C Wellons Iii; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatric Infect Dis Soc       Date:  2019-07-01       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.